Alizyme plc to techMARK - 19 October 2000
|
The Exchange takes great pleasure in welcoming Alizyme plc to techMARK -
the UK's market for companies with a proven commitment to technological innovation.
Cambridge-based Alizyme is a pharmaceutical company specialising in prescription drugs focusing on the treatment of obesity and related complaints. It is also developing a new system named COLAL - a method designed to administer drugs directly to the colon.
Alizyme's future plans include forming alliances with major pharmaceutical companies to share research and development costs.
For further information, please contact:
Company Sponsor
Nomura International
Tel. 020 7521 2000
Or visit
<% newurl = "server.URLencode("www.alizyme.co.uk")" %>
www.alizyme.co.uk
|
|